Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/18/2000 | WO2000009720A3 Cytochrome b5 from petunia |
05/18/2000 | WO2000009714A9 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
05/18/2000 | WO2000009699A3 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
05/18/2000 | WO2000009672A9 Dnazymes and methods for treating restenosis |
05/18/2000 | WO2000009658A3 Gene regulating circadian clock function and photoperiodism |
05/18/2000 | WO2000009650A9 A thermal/fluidic cycling device for the purpose of nucleic acid hybridization |
05/18/2000 | WO2000009560A3 Generation of modified molecules with increased serum half-lives |
05/18/2000 | WO2000009525A3 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
05/18/2000 | WO2000008193A3 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
05/18/2000 | WO2000008181A3 Chp polypeptide, a ligand of pak65 |
05/18/2000 | WO2000008141A3 Short oligonucleotides for the inhibition of vegf expression |
05/18/2000 | WO2000008140A3 Antisense oligonucleotides for the inhibition of vegf expression |
05/18/2000 | WO2000006746A8 Methods and means for inducing tolerance to stress |
05/18/2000 | WO2000006597A3 Endogenous constitutively activated g protein-coupled orphan receptors |
05/18/2000 | WO2000004158A3 Compositions and methods for fumonisin detoxification |
05/18/2000 | WO2000002910A9 Human fast-1 gene |
05/18/2000 | WO1999064562A3 Expression control elements from genes encoding starch branching enzymes |
05/18/2000 | WO1999061467A3 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
05/18/2000 | WO1999060137A3 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
05/18/2000 | WO1999060014A3 Methods and compounds for modulating nuclear receptor coactivator binding |
05/18/2000 | WO1999052415A3 Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor |
05/18/2000 | WO1999024470A8 Mammalian milk growth factor |
05/18/2000 | DE19940749A1 Integrated synthesis and analysis method e.g. for polymers, comprises a carrier body provided with immobilized receptors to provide respective channels before contact with sample and subsequent analysis |
05/18/2000 | DE19905082C1 Identification of methylation patterns of cytosine in genome DNA comprises chemical treatment to produce different base pairing behavior between cytosine and 5-methylcytosine |
05/18/2000 | DE19852757A1 Promotoren zur Genexpression in Wurzeln von Pflanzen Promoters for gene expression in roots of plants |
05/18/2000 | DE19852195A1 Neue Expressionskassette zur Expression von beliebigen Genen in Pflanzensamen New expression cassette for expression of any genes in plant seeds |
05/18/2000 | DE19850718C1 Zellpermeabilität-vermittelndes Polypeptid Cell permeability-mediating polypeptide |
05/18/2000 | CA2848113A1 Polypeptides having lysophospholipase activity and nucleic acids encoding same |
05/18/2000 | CA2354182A1 Polypeptides having lysophospholipase activity and nucleic acids encoding same |
05/18/2000 | CA2352383A1 Plastid transformation of solanaceous plants |
05/18/2000 | CA2351167A1 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model |
05/18/2000 | CA2351145A1 Vaccine against papillomatous digital dermatitis (pdd) |
05/18/2000 | CA2351019A1 Htfiiia human gene and coded htfiiia protein |
05/18/2000 | CA2351017A1 Catfiiia candida albicans tfiiia gene (catfiiia) and the coded catfiiia protein |
05/18/2000 | CA2350827A1 Screening system for zinc finger polypeptides for a desired binding ability |
05/18/2000 | CA2350775A1 Chlamydia pneumoniae genome sequence |
05/18/2000 | CA2350771A1 Chemokine .beta.-7 |
05/18/2000 | CA2350621A1 Human secretory protein-61 |
05/18/2000 | CA2350388A1 Human hydrolase proteins |
05/18/2000 | CA2350339A1 Pholasin |
05/18/2000 | CA2350335A1 Host cells expressing recombinant human erythropoietin |
05/18/2000 | CA2350183A1 Use of an enterobacterium protein ompa for specific targeting towards antigen-presenting cells |
05/18/2000 | CA2350182A1 Connective tissue growth factor (ctgf) and methods of use |
05/18/2000 | CA2350169A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey |
05/18/2000 | CA2350167A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
05/18/2000 | CA2350122A1 Method for the massive culture of cells producing recombinant human erythropoietin |
05/18/2000 | CA2350087A1 Chromosome 17p-linked prostate cancer susceptibility gene |
05/18/2000 | CA2350086A1 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
05/18/2000 | CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
05/18/2000 | CA2349950A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey |
05/18/2000 | CA2349859A1 Stabilized nucleic acid compositions and methods of preparation and use thereof |
05/18/2000 | CA2349848A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
05/18/2000 | CA2349815A1 Human cell surface receptor proteins |
05/18/2000 | CA2349814A1 Cytokine signal regulators |
05/18/2000 | CA2349761A1 Corticosteroid synthesis-associated genes |
05/18/2000 | CA2349679A1 Modified exosomes and uses |
05/18/2000 | CA2349644A1 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
05/18/2000 | CA2349502A1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
05/18/2000 | CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies |
05/18/2000 | CA2349496A1 Delivery of superoxide dismutase to neuronal cells |
05/18/2000 | CA2349449A1 Cell surface glycoproteins |
05/18/2000 | CA2349445A1 Antisense oligomer |
05/18/2000 | CA2349439A1 Methods and formulations for the separation of biological macromolecules |
05/18/2000 | CA2349437A1 Hypersensitive response elicitor-induced stress resistance |
05/18/2000 | CA2348821A1 Polynucleotide crosslinking agents |
05/18/2000 | CA2348775A1 Method to control gene expression in bacteria, namely rhizobiaceae, to improve root nodule development, nitrogen fixation and plant biomass production |
05/18/2000 | CA2348699A1 Virulence genes and proteins, and their use |
05/18/2000 | CA2348696A1 A method for reproducing molecular arrays |
05/18/2000 | CA2348609A1 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait |
05/18/2000 | CA2348480A1 Herbicide resistant rice |
05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
05/18/2000 | CA2348155A1 Nucleic acids encoding taxus geranylgeranyl diphosphate synthase, and methods of use |
05/18/2000 | CA2347970A1 Use of dna identification techniques for the determination of genetic material of cocoa in fermented or roasted beans and chocolate |
05/18/2000 | CA2347847A1 A method of treating tumors using fas-induced apoptosis |
05/18/2000 | CA2346962A1 Fk506-based regulation of biological events |
05/18/2000 | CA2345351A1 Disease resistance factors |
05/18/2000 | CA2316802A1 Method for generating gene expression profiles |
05/17/2000 | EP1001032A2 Recombinant retroviruses delivering vector constructs to target cells |
05/17/2000 | EP1001031A1 Parvovirus-vectors and their use |
05/17/2000 | EP1001030A1 Recombinant CELO virus and CELO virus DNA |
05/17/2000 | EP1001029A1 Method for increasing sucrose content of plants |
05/17/2000 | EP1001028A1 Gene encoding protein having aurone synthesizing activity |
05/17/2000 | EP1001027A2 Process for the reduction of pantothenic acid by amplification of nucleotide sequences coding for ketopantoate-reductase |
05/17/2000 | EP1001026A2 Riboflavinoverproducing strains of bacteria |
05/17/2000 | EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae |
05/17/2000 | EP1001024A2 Protein encoded by the trkB proto-oncogene, used in assay systems for neurothophin activity |
05/17/2000 | EP1001023A2 Frizzled-4, a putative Wnt-receptor |
05/17/2000 | EP1001022A1 CAMEL, an alternative translation product of the tumour antigen LAGE-1 |
05/17/2000 | EP1001021A1 Monoclonal antibody to human CD21, and its uses |
05/17/2000 | EP1001019A1 Transgenic animals harboring APP Allele having Swedish mutation |
05/17/2000 | EP1001018A2 Cellulases obtainable from alkalophilic Bacillus sp. ac13 |
05/17/2000 | EP1000661A1 Ultrathin-walled multiwell plate for heat block thermocycling |
05/17/2000 | EP1000543A1 A method for inducing resistance of plants to mycotoxin-producing fungi |
05/17/2000 | EP1000357A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
05/17/2000 | EP1000177A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
05/17/2000 | EP1000176A1 Computer method and system for correlating sequencing data by ms |
05/17/2000 | EP1000175A1 Amplification and other enzymatic reactions performed on nucleic acid arrays |
05/17/2000 | EP1000173A1 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers |
05/17/2000 | EP1000170A1 High specificity homocysteine assays for biological samples |
05/17/2000 | EP1000168A2 A swine hepatitis e virus and uses thereof |